NAD+ therapy (injections/IVs) excels, boosting levels, mitochondrial function, and energy.[20][21] Clinical evidence shows improvements in fatigue and metabolic markers, with some studies reporting enhanced quality of life
Semaglutide: Available now (shortages ongoing)
Some studies have demonstrated an increased risk of depression and anxiety in individuals taking GLP-1s, and, anecdotally, some patients report experiencing emotional numbing when taking GLP-1 medications." And, she warned, the drugs could exacerbate disordered eating for some people
RUO pages should separate published research findings from product claims, especially when search language drifts toward consumer, clinical-use, or product-performance framing
My energy is up, and I love what I see in the mirror
Reliable results depend on validated purity levels and exact chemical composition